Managing Partner, Ysios Capital Partners
JoŽl Jean-Mairet is co-founder partner of Ysios Capital Partners, a Barcelona-based venture capital firm with Ä70 Mio under management providing private equity financing to early, mid - and late-stage biotech and medtech companies. JoŽl oversees all operations including management, strategy and standard operations.
JoŽl is currently chairman of Cellerix, a Madrid-based adult stem cell therapy company that has raised over Ä54 Mio in equity in the last years, and was board observer of BioVex, a company acquired by Amgen early this year for up to $ 1bn.
Previous to Ysios, JoŽl co-founded GLYCART Biotechnology AG (ZŁrich, Switzerland) in March 2001 and was Chief Executive since inception. He raised over Ä15 Mio in three rounds of financing for GLYCART before the company was sold to F.Hoffmann-La Roche Ltd in July 2005 for Ä 152 Mio in cash.
JoŽl received a PhD in cell biology and immunotherapeutics from the Swiss Federal Institute of Technology in ZŁrich. He was elected one of the 50 key players in biotechnology in Switzerland in 2003 and earned several innovation awards for GLYCART, including the Wall Street Journal Europe Innovation Award in 2001.
The GLYCART-Roche transaction was lauded by European Venture Capital magazine as the "Venture Deal of the Year" (2005) in the Healthcare category.